A forty-seven-year-old woman presented multiple times with a reoccurring bronchopleural fistula and post-pneumonectomy multi-drug resistant empyema. In challenging cases like this, a multidisciplinary approach between thoracic and plastic surgery is imperative.
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Management of Recurrent Bronchopleural Fistula: A Multidisciplinary Approach for A Reconstructive Challenge
May 31, 2022
Successful Use of an Endobronchial Valve for Post-Operative Bronchocutaneous Fistula and Pneumothorax Necessitans
February 21, 2022
This video demonstrates the successful treatment of bronchocutaneous fistula and pneumothorax necessities with placement of an endobronchial valve.
July 12, 2021
In this article, Jacobs et al. provide a multi-institutional outcomes review of 200 consecutive patients with confirmed COVID-19 supported with ECMO. The mean time on ECMO was 15 days with survival on VV-ECMO of 46.3% and survival on VA-ECMO of 25%.
March 11, 2021
This video demonstrates the video-assisted thoracoscopic management of a ruptured pulmonary hydatid cyst.
Endoscopic Transnasal Drainage for Management of Iatrogenic Esophageal Perforation and Mediastinal Abscess
March 5, 2021
The authors present a video illustrating the endoscopic management and drain placement for an iatrogenic proximal esophageal perforation with uncontrolled mediastinal sepsis.
December 22, 2020
Montgomery et al. report on untreated infectious aneurysms of native coronary artery and aortocoronary bypass grafts are associated with high mortality.
Thoracic Surgery During the Coronavirus Disease 2019 (COVID-19) Pandemic in Madrid, Spain: Single-Centre Report
November 23, 2020
Hoyos Mejia et al. present a single center report regarding the outcome of thoracic surgery during the COVID-19 pandemic. They recorded a significant reduction in thoracic surgical cases. They observed five cases of coronarvirus infection in 101 surgical patients within 14 days after surgery.
Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis From Phase 3 Study
November 9, 2020
In a press release early this morning, Pfizer and BioNTech accounced the results of their vaccine candidate against SARS-CoV-2 in the first interim efficacy analysis of its Phase 3 clinical study.
The Impact of Coronavirus Disease 2019 on the Practice of Thoracic Oncology Surgery: A Survey of Members of the European Society of Thoracic Surgeons
October 23, 2020
Depypere et al. report on a survey among members of the European Society of Thoracic Surgeons (ESTS) regarding the impact of coronarvirus disease 2019 on thoracic oncology surgery. They recorded an almost universal impact on surgical practice regardless of the country and the numbers of COVID-19 infected patients.
October 12, 2020
This video discusses how thoracic surgeons can protect themselves during worst-case scenarios during the COVID-19 pandemic, from case triage to service reactivation.